top of page

Mohassel Lab
Johns Hopkins School of Medicine
Department of Neurology, Neuromuscular Division
Pathology Building 635/636

Our Mission
-
Understand pathogenic mechanisms of monogenic neuromuscular diseases
-
Identify therapeutic targets
-
Conduct proof-of-concept preclinical studies
-
Enable and conduct early-phase clinical trials of candidate therapies
​

-
Collagen VI-related muscular dystrophy
-
Serine palmityoltransferase (SPT)-related ALS
-
Cell-based therapies for Duchenne muscular dystrophy
​
Disease Models
-
Patient-derived fibroblasts
-
iPSC-derived cells
-
Transgenic mouse models
​

bottom of page